Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 2 | $2.21 | $3.88 | $3.04 |
Q2 2025 | 1 | $2.35 | $2.35 | $2.35 |
Q3 2025 | 1 | $2.27 | $2.27 | $2.27 |
Q4 2025 | 1 | $2.49 | $2.49 | $2.49 |
Q1 2026 | 1 | $2.78 | $2.78 | $2.78 |
Q2 2026 | 1 | $3.31 | $3.31 | $3.31 |
Q3 2026 | 1 | $3.22 | $3.22 | $3.22 |
Q4 2026 | 1 | $3.67 | $3.67 | $3.67 |
Nutex Health, Inc. last posted its earnings results on Monday, March 31st, 2025. The company reported $11.12 earnings per share for the quarter, topping analysts' consensus estimates of $-0.09 by $11.21. The company had revenue of 257.62 M for the quarter and had revenue of 479.95 M for the year. Nutex Health, Inc. has generated $10 earnings per share over the last year ($10.23 diluted earnings per share) and currently has a price-to-earnings ratio of 12.99. Nutex Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
04/30/2025 | Q4 2024 | N/A | $11,954.48 | N/A | $81.11 M | $257.62 M |
11/07/2024 | Q3 2024 | N/A | -$1,723.19 | N/A | $73.22 M | $78.79 M |
08/08/2024 | Q2 2024 | -$0.29 | -$0.07 | 0.22 | $68.20 M | $76.08 M |
05/08/2024 | Q1 2024 | N/A | -$0.08 | N/A | $64.80 M | $67.45 M |
04/30/2024 | Q4 2023 | N/A | -$7.86 | N/A | $69.70 M | $69.67 M |
11/09/2023 | Q3 2023 | -$1.50 | -$1.50 | 0 | $63.00 M | $62.72 M |
08/09/2023 | Q2 2023 | -$1.50 | -$0.98 | 0.52 | $62.05 M | $58.92 M |
05/15/2023 | Q1 2023 | -$3.00 | -$1.27 | 1.73 | N/A | $56.33 M |
03/02/2023 | Q4 2022 | N/A | -$2.35 | N/A | N/A | $53.72 M |
11/21/2022 | Q3 2022 | N/A | -$100.04 | N/A | N/A | $28.40 M |
08/22/2022 | Q2 2022 | N/A | -$5.48 | N/A | N/A | $58.05 M |
05/13/2022 | Q1 2022 | N/A | -$4.19 | N/A | N/A | $6.21 M |
03/31/2022 | Q4 2021 | N/A | $3.23 | N/A | N/A | $65.03 M |
11/15/2021 | Q3 2021 | N/A | $13.50 | N/A | N/A | $117.97 M |
08/16/2021 | Q2 2021 | N/A | $6.85 | N/A | N/A | $62.81 M |
05/24/2021 | Q1 2021 | N/A | -$1.12 | N/A | N/A | $2.01 M |
04/02/2021 | Q4 2020 | N/A | $8.50 | N/A | N/A | $106.13 M |
11/16/2020 | Q3 2020 | N/A | $0.34 | N/A | N/A | $560.93 K |
08/19/2020 | Q2 2020 | N/A | $0.05 | N/A | N/A | $643.45 K |
06/29/2020 | Q1 2020 | N/A | -$0.24 | N/A | N/A | $664.76 K |
Nutex Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based offlast year's report dates.
In the previous quarter, Nutex Health, Inc. (:NUTX) reported $11.12 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.09 by $11.21.
The conference call for Nutex Health, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Nutex Health, Inc.'s latest earnings report can be read online.
Nutex Health, Inc. (:NUTX) has a recorded annual revenue of $479.95 M.
Nutex Health, Inc. (:NUTX) has a recorded net income of $52.18 M.Nutex Health, Inc. has generated $10.23 earnings per share over the last four quarters.
Nutex Health, Inc. (:NUTX) has a price-to-earnings ratio of 12.99 and price/earnings-to-growth ratio is 0.02.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED